ALSO NOTED: MicroIslet warns of cash shortage; Invitrogen, Signalomics in pact; and much more...

> San Diego-based MicroIslet is warning investors it only has enough money to fund operations through June. Report

> Invitrogen and Germany's Signalomics have inked a pact to collaborate on nanotech-based approaches to diagnosing cancer. Report

> The FDA has granted final approval for Mayne Pharma's abbreviated New Drug Application for Mitoxantrone Injection, USP packaged in 20mg, 25mg and 30mg multiple-dose presentations. Release

And Finally… A small study suggests that tanning can be physically addictive. Article

Suggested Articles

One day after its Opdivo-paired prospect flopped, Five Prime is farming out some preclinical antibodies to keep its clinical-stage pipeline alive.

Gilead has a new head of research biology: Michael Quigley, Ph.D., an alum of MedImmune, Janssen and Dana Farber, who joins from Bristol-Myers Squibb.

The back-to-back pivotal successes tee Incyte up to talk to regulators about bringing the JAK inhibitor to market.